Table 1 Baseline characteristics, clinical presentation, and outcome of diabetic patients with controlled or uncontrolled glycemia

Male

12 (63.2)

59 (71.1)

0.498

0.952

Age in years

70.6 ± 9.6

62.8 ± 14.9

0.017

Underlying diseases

 Malignancy

1 (5.6)

10 (12.7)

0.683

0.367

 Alcoholism

1 (5.3)

4 (4.8)

1.000

0.655

 Chronic kidney disease

1 (5.6)

8 (10.3)

1.000

0.311

 Liver cirrhosis

0 (0)

2 (2.4)

1.000

0.494

 Congestive heart failure

0 (0)

2 (2.4)

1.000

0.392

 Chronic lung disease

0 (0)

1 (1.2)

1.000

0.549

Newly diagnosed diabetes

4 (21.1)

21 (25.3)

1.000

0.995

Origin

 Cryptogenic

15 (78.9)

77 (92.8)

0.087

0.090

 Biliary tract origin

1 (5.3)

5 (6.0)

1.000

0.785

Abscess locations

 Right lobe

11 (57.9)

44 (53.0)

0.791

0.407

 Left lobe

5 (26.3)

19 (22.9)

 Both lobes

3 (15.8)

20 (24.1)

Abscess size

 < 5 cm

9 (47.4)

36 (43.4)

1.000

0.707

 5 ~ 10 cm

9 (47.4)

39 (47.0)

 >; 10 cm

1 (5.3)

8 (9.6)

Gas forming

0 (0)

12 (14.5)

0.116

0.126

Multiple abscesses

8 (42.1)

29 (34.9)

0.558

0.791

Initial laboratory value

 Leukocyte count, × 10³/μL

12.4 ± 3.8

13.5 ± 6.0

0.165

0.417

 Platelet, × 10³/μL

195 ± 87

229 ± 121

0.145

0.442

 C-reactive protein, mg/dL

18.8 ± 9.2

20.0 ± 9.8

0.487

0.779

 Glucose, mg/dL

193 ± 76

318 ± 168

0.007

0.004

Treatment

 Antibiotics + drainage

16 (84.2)

69 (83.1)

1.000

0.894

 Antibiotics + operation

1 (5.3)

3 (3.6)

0.568

0.525

 Antibiotics only

2 (10.5)

11 (13.4)

1.000

0.557

Metastatic infections

0 (0)

12 (14.5)

0.116

0.077

Outcome

 Hospitalization days

26.2 ± 12.1

28.1 ± 19.0

0.692

0.428

 Intensive care unit admission

2 (10.5)

12 (14.5)

1.000

0.849

 Mortality

0 (0)

3 (3.6)

1.000

0.359